Gene therapy, the correction of dysfunctional or deleted genes by supplying the lacking component, has long been awaited as a means to permanently treat or reverse many genetic disorders. To achieve this, therapeutic DNA must be delivered to the nucleus of cells using a safe and efficient delivery vector. Although viralbased vectors have been utilized extensively due to their innate ability to deliver DNA to intact cells, safety considerations, such as pathogenicity, oncogenicity and the stimulation of an immunological response in the host, remain problematical. There has, however, been much progress in the development of safe nonviral gene-delivery vectors, although they remain less efficient than the viral counterparts. The major limitations of non-viral gene transfer reside in the fact that it must be tailored to overcome the intracellular barriers to DNA delivery that viruses already master, including the cellular and nuclear membranes. In particular, nuclear transport of the therapeutic DNA is known to be the rate-limiting step in the gene-delivery process. Despite this, much progress had been made in recent years in developing novel means to overcome these barriers and efficiently deliver DNA to the nuclei of intact cells. This review focuses on the nucleocytoplasmic delivery of DNA and mechanisms to enhance to nonviral-mediated gene transfer.
INTRODUCTION
Many common debilitating human disorders, such as cystic fibrosis, diabetes and numerous cancers, have an underlying genetic cause. The failure of pharmacological approaches to cure a number of these diseases has meant that gene therapy, defined as correction of dysfunctional or deleted genes by supplying the absent component, has long been awaited as a means to permanently treat or reverse such disorders. To achieve this, therapeutic DNA must be delivered to the nucleus of cells using a safe and efficient delivery vector. Although viral-based vectors have been utilized extensively due to their innate ability to deliver DNA to intact cells, safety considerations, such as pathogenicity, oncogenicity and the stimulation of an immunological response in the host, remain problematical [1] . There has, however, been much progress in the development of safe non-viral gene-delivery vectors, although they remain less efficient than the viral counterparts [2] .
The major limitations of non-viral gene transfer reside in the fact that it must be tailored to overcome the intracellular barriers to DNA delivery that viruses already master. This results in an overall level of transfection efficiency that is surprisingly low, with less than 1 % of the DNA that is taken up by a cell being expressed [3, 4] .
BARRIERS TO GENE TRANSFER
Multiple cellular barriers reside between the nucleus and the extracellular milieu, which represent layers of protection from the entry of extrachromosomal DNA and therefore therapeutic plasmid DNA (Figure 1 ) [5] . These include binding of the vector to the cell surface and subsequent transit through the plasma membrane. Depending on whether this is achieved through direct or indirect means, the vector may become encapsulated in an endosome, from which it must escape in order for the DNA to avoid degradation when the endosome fuses with a lysosome. If the vector reaches the cytoplasm, it must pass through the crowded network of the intracellular cytoskeleton, without being degraded by cytosolic nucleases, in order to reach the nucleus. The nucleus itself is surrounded by a double membrane, the NE (nuclear envelope), through which the vector must pass in order to reach the nucleus and ultimately be transcribed. This rate-limiting step is recognized as the predominant cause of the low transfection efficiency of non-viral gene-delivery vectors.
The most common methods used to overcome these barriers in non-viral gene delivery include lipid formulation, cationic polymers or peptides, or combinations thereof [5] . Further functional moieties can be included to generate modular vectors with additional capabilities. These moieties include ligands for cell-specific targeting, endosomolytic agents to increase endosomal escape and NLSs (nuclear localization signals; see below) to target DNA specifically to the nucleus [6] [7] [8] .
The cell membrane as a barrier
The plasma membrane of mammalian cells is a dynamic lipophilic structure that restricts the passage of large, hydrophilic or charged molecules [5] . DNA, being both large and negatively charged, does not easily pass through this barrier without an appropriate delivery system. Many non-viral vectors are also large and hydrophilic and unable to cross the cellular membrane readily. Thus endocytosis has been established as the main route of cellular entry for non-viral vectors ( Figure 1 , step 1a) [9, 10] . This adds another layer of complexity to the problem of gene delivery, in
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Figure 1 Barriers to non-viral gene delivery
Representation of the route travelled by a non-viral gene-delivery vector carrying therapeutic DNA to the nucleus. A non-viral vector, formed by interaction of the DNA with a carrier compound, must cross the plasma membrane to enter the cell. This can be via several routes, including endocytosis-based entry (1a), direct physical entry routes, such as electroporation or ballistic delivery (1b), or direct entry via protein transduction (1c). Depending on the mode of cellular entry, the vector may become encapsulated in an endosome (2) , from which it must escape (3a) or it will become degraded when the endosome fuses with a lysosome (3b). The DNA will at some point be subjected to degradation by cytosolic nucleases (4), as it traverses through the cytoplasm to reach the nucleus. Finally, the vector must undergo nuclear transport (5) through NPCs embedded in the NE in order to gain access to the nucleoplasm. Once in the nucleus, the DNA may (6a) or may not (6b) need to be uncoated, depending upon the vector used, before it can ultimately be transcribed (7) .
that non-viral vectors tend to be internalized into membranebound endosomes, so that subsequent intracellular release from these is essential for efficient gene transfer ( Figure 1 , step 3a) [11] . Therefore non-endocytotic-based methods of delivery have also been explored, including physical methods, such as electroporation [12] or ballistic particle-mediated delivery [13] (Figure 1 , step 1b), and more recently the use of PTDs (protein transduction domains) ( Figure 1 , step 1c), which mediate cellular entry in an energy-and receptor-independent fashion [14, 15] .
Endocytotic uptake pathways
Endocytosis refers to the cellular uptake of macromolecules and solutes into membrane-bound vesicles, which are derived from pinched-off sections of the cell membrane [5] . Various endocytotic pathways are active in cells, which differ in the composition of the membrane coat (if present), in the size of the vesicles generated and the intracellular fate of the internalized particle [16] .
Receptor-mediated endocytosis. Receptor-mediated endocytosis is the best-described endocytotic pathway [16, 17] , occurring in all mammalian cells and allowing for the continuous uptake of essential nutrients, growth factors, antigens and pathogens [5] . The process involves the recognition of a ligand by a specific cellsurface receptor, followed by invagination of the membrane to form a vesicle. This invagination is energy-dependent and relies upon clathrin for the formation of membrane pits that are critical to the process [17] . The process is also strongly dependent on both the actin cytoskeleton and the microtubular network, which are involved in pinching off the membrane [16] .
Receptor-mediated endocytosis can be utilized specifically by non-viral gene-delivery vectors by incorporating specific ligands into the vector (e.g. [18] [19] [20] ). This not only results in increased internalization of the vector, but can also be utilized to target specific cell types, on the basis of the repertoire of expressed cell-surface receptors [5] . For example, introducing a galactose moiety into the DNA-delivery vector can specifically target hepatocytes, because liver parenchymal cells exclusively express large numbers of high-affinity asialoglycoprotein receptors [20] . Furthermore, transferrin, an iron-binding glycoprotein, has been extensively used as a tumour-targeting ligand, because transferrin receptors are overexpressed in rapidly dividing cells due to the increased cellular need for iron [21, 22] . The folate receptor is another receptor that is overexpressed in tumour cells, and has also been employed for tumour-cell-specific targeting [23] .
The downside of these approaches is that the vectors become trapped in endosomes and are subsequently degraded by lysosomal enzymes. These can actually be regarded as two separate problems, since prevention of lysosomal degradation does not result in endosomal escape, but rather in the accumulation of the vector in intracellular vesicles [5] .
Various strategies have been employed to enhance the endosomal escape of non-viral vectors, such as inclusion of endosomolytic peptides from the N-terminus of the influenza virus haemagglutinin or the use of pH-sensitive liposomes [22, 24, 25] . Other lipids and some cationic polymers, such as polyethylenimine, also enhance cytosolic release of vectors from endosomes through different mechanisms [26, 27] .
Caveolae-mediated endocytosis. Caveolae-mediated endocytosis, otherwise known as potocytosis, is a mechanism by which both small and large molecules can be internalized by caveolae, which are small hydrophobic microdomain regions of the membrane that are characterized by the filamentous coat of caveolins that line their inner surface [28] .
It is generally believed that caveolar uptake does not lead to degradation by lysosomes, making it an attractive mode of entry for non-viral gene-delivery vectors [5, 28] . There is some evidence that caveolae play a role in the uptake of cationic polymer-DNA complexes and possibly in the uptake of some PTDs (see below) [29, 30] . The small size of caveolae and their slow internalization rate, however, may hinder their use in gene-therapy applications [5] .
Macropinocytosis. Macropinocytosis allows cells to engulf large molecules and, in this respect, is similar to receptor-mediated endocytosis, but does not rely upon a specific receptor. Instead, the stimulation of a cell-signalling cascade involving Rho GTPases results in actin-driven closure of lamellipodia at the sites of membrane ruffles [31] , forming large irregular vesicles [16] .
Macropinocytosis is gaining increasing attention as a possible mode of entry for gene-delivery vehicles, because it has advantages over other routes in terms of increased uptake of macromolecules, avoidance of lysosomal degradation and relative ease of escape due to the leaky nature of the vesicles. It has been demonstrated that the uptake of peptides from the HIV-1 Tat (transactivator of transcription) occurs via macropinocytosis [32, 33] . It has also been shown that inhibition of macropinocytosis results in impaired gene expression when delivery is mediated by an octa-arginine peptide [34] . However, macropinocytosis has also been shown to inhibit gene delivery mediated by polylysine [35] . It has been suggested that the lumen of macropinosomes is not sufficiently acidic enough to allow the escape of polylysine peptides, which may not be the case for poly-arginine [5] .
Non-endocytotic mechanisms of cellular entry
Due to the immense problems associated with endosomal escape and lysosomal degradation of non-viral gene-delivery vehicles, it would be advantageous to target other routes of cellular entry that do not result in encapsulation within an endosome.
Permeabilization is a technique that has been applied in vitro to transfect mammalian cells. In this technique, agents such as streptolysin O are used to generate pores in the cellular membrane, so that the vector can gain entry directly to the cytoplasm [36] . This technique can be highly detrimental to the viability of the cell, however, and is not a viable alternative for use in vivo. In a similar manner, microinjection of cells allows for rapid delivery to either the nucleus or the cytoplasm using glass capillary pipettes, but it is really restricted to use in vitro and ex vivo [37] .
Electroporation on the other hand has been used successfully in situ to deliver therapeutic genes to sites in mice and rats [38] . Electroporation involves the use of an electrical impulse to induce transient structural changes in the cell membrane, generating pores in the cell through which DNA can pass [39] . This technique is relatively cost-effective, simple to perform and can be performed both in vitro and in situ [40] . In situ electroporation seems to be particularly suited to skeletal muscle transfer, either to produce therapeutic proteins systemically or to treat muscle disorders [38, 41] .
DNA can also be transferred into cells using ballistic particlemediated delivery. In this process, DNA is precipitated on to highdensity microparticles, usually gold, of 1-3 µm in diameter and accelerated into cells using a helium-driven device [13] . Although this approach has been widely used both in vitro and in vivo, it is an expensive technique and most studies have focused on epidermal tissues, with little known to date regarding its use in visceral tissue [13, 42] .
Perhaps the most exciting development in the field of nonendocytotic delivery of DNA has been the discovery of a class of proteins/peptides known as CPPs (cell-penetrating proteins/peptides), which have been shown to enter cells in an apparently energy-and receptor-independent fashion [15, 43] . This process of translocation across cell membranes is known as protein transduction and is usually mediated by short distinct domains, typically less than 20-30 residues, which are usually highly rich in basic amino acids [15] . These domains are known as PTDs, but their mechanism of entry is still poorly understood. Many proteins belong to the CPP family, including HIV-1 Tat [44] , although its mechanism of entry is now under considerable debate, the homeodomain of antennapedia from Drosophila [45] , herpes simplex virus 1 protein 22 [46] and, more recently, the four core histone proteins H2A, H2B, H3 and H4 [47] , many of which have been used successfully for gene-transfer applications [15] . CPPs often have many desirable features for the delivery of a wide range of cargoes, including DNA, into mammalian cells, both in vitro and in vivo, including efficacy, nuclear targeting, applicability to a wide variety of cell types and no apparent cargo size restrictions or immunogenic, antigenic or inflammatory properties [14, 15] . One potential drawback with their use is that, although CPPs themselves utilize protein transduction to enter into cells, often endocytosis is the method used when CPPs are coupled to large cargoes, such as DNA [15, 48, 49] . Despite this, significant enhancement of non-viral gene transfer has occurred by the use of these peptides. CPPs and their therapeutic applications have been reviewed previously [14, 15] .
NE
The NE is now recognized as one of the most substantial barriers for DNA delivery to cells [50] . This was demonstrated originally more than 20 years ago when it was found that microinjection of pBR322-based plasmids into the cytoplasm resulted in no gene expression, whereas injection into the nucleus gave expression in 50-100 % of cells [3] . Delivery of DNA to the nucleus is easier in proliferating cells than in quiescent cells, as the NE is temporarily broken down during cell division [51] . In addition, both the rate of nuclear uptake and the functional size of the transport channels are greater in proliferating cells [52] . In nondividing cells, the NE acts as a selective barrier around the nucleus, impeding the nuclear entry of therapeutic DNA, as well as nonviral gene-delivery vehicles.
NUCLEOCYTOPLASMIC TRAFFICKING OF DNA

Conventional nuclear transport
NPC (nuclear pore complex)
In 1962, Feldherr demonstrated that colloidal gold particles passed through pores in the NE to enter the nucleus [53] . It has since been shown that all passive and active transport into and out of the nucleus takes place via these NE-embedded NPCs [54, 55] . The NPC has a tripartite structure, with a central domain and cytoplasmic and nuclear rings, and consists of approx. 50 different proteins known as nucleoporins (reviewed in [55] ). Kinetic studies have shown that each NPC can accommodate approx. 1000 translocation events per s, including both passive and active transport [56] .
Figure 2 NLS-mediated nuclear import pathways
In classical nuclear import, the NLS found in cargo bound for the nucleus is recognized by the Imp α subunit of the Imp α/β heterodimer (1). However, there are also many examples where Imp β or one of its many homologues can mediate nuclear import or cargo proteins independently of Imp α (2). In both cases, transient interactions between the Imp β and the nucleoporin proteins that line the NE-embedded NPCs mediate translocation into the nucleus. Once inside, RanGTP binds to Imp β (3), releasing Imp α and the cargo into the nucleoplasm (4a and 4b). RanGTP itself is then recycled back to the cytoplasm (5), where it is converted into its RanGDP state (not shown). An animated version of this Figure can be found at http://www.BiochemJ.org/bj/406/0185/bj4060185add.htm Smaller molecules can pass through the NPC via passive diffusion, whereas molecules > 45 kDa are excluded from the nucleus unless they possess a specific targeting signal, known as an NLS [57, 58] , which is recognized by members of the Imp (importin; also known as karyopherin) superfamily of nuclear import transporters [58, 59] .
Imps and conventional nuclear transport
Conventional NLS-mediated nuclear transport ( Figure 2) involves recognition of the NLS by the Imp α subunit of the Imp α/β heterodimer [60] . The N-terminus of Imp α contains a flexible arginine-rich 41-amino-acid IBB (Imp β-binding) domain [60, 61] . The IBB domain also plays a critical role in autoinhibition, in that when it is not bound to Imp β, an autoinhibitory sequence within the IBB domain binds to the NLS-binding pocket, reducing the affinity of Imp α for NLSs [62] .
Imp β has distinct domains for binding to Imp α [63] , the adaptor protein Ran and two binding sites for the hydrophobic FG (Phe-Gly) repeats of certain nucleoporins, which allows the Impcargo complex to dock at the distal end of the NPCs cytoplasmic filaments [54, 64, 65] . The complex is then transferred into the central channel of the NPC in order to translocate the distance of 100-120 nm to the nucleoplasmic side [66] .
This translocation is thought to involve transient association/ dissociation interactions of Imp β with nucleoporins throughout the central pore, but the exact mechanism remains unknown [59] . Several models have been proposed, including: the affinitygradient model, in which Imp β is proposed to have increased affinity for subsequent nucleoporins across the central channel, thus driving translocation [67] ; the Brownian affinity gate model (or virtual gating), in which it is proposed that the interaction of Imps with nucleoporins on the cytoplasmic side of the NPC increases the local concentration of cargo proteins, allowing for rapid diffusion through the pore to occur [68] ; the selectivephase model, which proposes that the nucleoporins within the central channel interact with each other via weak hydrophobic interactions, thereby blocking the passage of macromolecules greater than 39 nm in diameter [56] ; and, more recently, a combined mechanistic transport model, which combines the positive aspects of all the above models [69] . All of these models point to the importance of specific nuclear targeting for efficient nuclear import (for a review of these models, see [51] ).
Once inside the nucleus, the Imp-cargo complex is dissociated by binding of the monomeric guanine-nucleotide-binding protein Ran, in its GTP-bound form (RanGTP), to Imp β, which actively displaces Imp α [64, 70] . Ran itself is found on both sides of the NE, but the Ran GAP (GTPase-activating protein) is found predominantly in the cytoplasm and the Ran GEF (guanine-nucleotide-exchange factor) is found predominantly in the nucleus, bound to chromatin [70, 71] . The actions of these two factors create an asymmetrical distribution, with RanGDP located in the cytoplasm and RanGTP within the nucleus. After dissociation of Imp α and the cargo, Imp β is shuttled back to the cytoplasm bound to RanGTP, where conversion into RanGDP releases Imp β so that it can bind to new cargoes [70, 72] . Nuclear Ran is replenished by transport of RanGDP into the nucleus by its own specific nuclear transporter NTF2 (nuclear transport factor 2), which mediates transport through the NPC via interaction with
Figure 3 SV40 T-ag NLS
The SV40 T-ag contains several sequences that regulate its nuclear targeting, including: (A) an Imp α/β-recognized NLS, which is regulated by (B), an upstream CK2 phosphorylation site (residues 111-115) which operates in synergy with Ser 120 to enhance Imp α/β recognition of the NLS by approx. 100-fold. (C) The NLS is also regulated by an inhibitory cdc2/cdk2 (cell division cycle 2 kinase /cyclin-dependent kinase 2) site at Thr 124 . Phosphorylated residues are shown in blue.
FG-repeat-containing nucleoporins, in analogous fashion to Imp β [73, 74] .
It has also been shown that as many as 20 different Imp β homologues and Imp β itself can mediate nuclear import of a variety of proteins in an analogous fashion to Imp α/β, but without the requirement for Imp α [75] [76] [77] [78] [79] [80] [81] . This implies that the role of Imp α in conventional nuclear transport is largely as an adaptor protein [82] .
NLSs
Nuclear targeting of the various classes of import cargoes requires distinct NLSs [51, 83] , which can be subdivided into classical and non-classical sequences [84] . Classical NLSs are characterized by stretches of basic charged amino acids. Different examples of classical NLS sequences exist, of which the best understood are those that resemble the SV40 (simian virus 40) T-ag (large tumour antigen), which is a monopartite NLS comprising a single stretch of basic amino acids (PKKKRKV 132 ; Figure 3 ) [85, 86] . Residues flanking the T-ag NLS have also been demonstrated to regulate nuclear transport, whereby inclusion of an upstream CK2 kinase phosphorylation site (SSDDE 115 ) and mutation of an inhibitory cdc2 (cell division cycle 2 kinase) phosphorylation site (ST 124 ) to generate op-T-NLS (optimized Tag NLS; SSDDEATADSQHAAPPKKKRKV) results in a greater affinity for Imp α/β and 100-fold faster nuclear import [7, 87] .
Bipartite NLSs, on the other hand, consist of two stretches of basic amino acids separated by a spacer region of 10-12 residues, and are typified by the NLS of the Xenopus protein nucleoplasmin (KRPAATKKAGQAKKKK 170 ) [88] . A third less-defined class of NLSs are those that resemble the yeast homeodomain-containing protein MATα2 (NKIPIKDLLNPQ 13 and VRILESWFAKNI 159 ) [89, 90] , which consists of charged/polar residues that are interspersed with non-polar residues.
Each of these classes are typically recognized by the Imp α/β heterodimer, but there are many examples of classical NLSs that are recognized by Imp β family members alone [51, 84] , such as the NLSs of the T-cell protein tyrosine phosphatase [91] , the yeast transcriptional activator GAL4 [92] , SRY (sex-determining region of the Y chromosome) [93] , transcription factors, such as CREB (cAMP-response-element-binding protein) and AP-1 (activator protein-1) [94] , and histone proteins [75, 77, 95] . Although these NLSs are less well understood, many of them show similarity to the IBB domain of Imp α [51, 84] . However, a second cargobinding site has been identified on Imp β, which is distinct from the IBB-domain-binding site, that can bind to NLSs without the need for Imp α or other adaptor proteins [96] .
There are also examples of non-classical NLSs without the stretches of basic amino acids, of which the best-known example is the largely hydrophobic 38-residue M9 sequence of the human mRNA-binding protein hnRNP A1 (heterogeneous nuclear ribonucleoprotein A1) [79] .
Nucleocytoplasmic transport of DNA
Due to negligible transcriptional activity of liposome-complexed plasmid DNA both in vitro and in vivo, it has been hypothesized that dissociation of these complexes may occur prior to transport of the DNA into the nucleus [97] . However, this is not an absolute requirement, as suggested by the fact that DNA complexed to PEI (polyethylenimine), a DNA-condensing agent, has been identified in the nucleus of cells after delivery [98] [99] [100] . Collectively, these reports show that DNA is exposed to the cytosolic milieu prior to and during transport to the nucleus, and this may explain the observations that nuclear delivery of the DNA is the rate-limiting step in gene delivery by non-viral mechanisms [3, 4, 97, 98, 100, 101] .
The nucleocytoplasmic trafficking of plasmid DNA has been investigated by several different means, and it has been estimated that at least 10 5 -10 6 plasmids per cell are required for nuclear uptake and subsequent transcription in non-dividing cells [102] . Measurement of the nucleocytoplasmic transport efficiency demonstrated that, although expression of thymidine kinase could be detected in 50-100 % of mouse fibroblast cells when the vector was microinjected into the nucleus, no significant expression was detected in any of the 1000 cytoplasmically injected cells, corresponding to expression of only an estimated 0.001-0.1 % of the introduced vector [3] . Similar results were also observed in Xenopus oocytes, in which microinjection of a labelled β-galactosidase expression vector into the nucleus resulted in robust gene expression, but cytoplasmic injection did not [97] . These results have been verified by several others [4, 10, 101, 103, 104] ; most recently, comparison of luciferase expression of single cells demonstrated that only 1 in every 1000-5000 cytosolic plasmid DNA molecules reached the nucleosol and was transcribed [105] .
Cytoplasmic impediments to DNA nuclear delivery
Diffusion of DNA through the cytosol
Once microinjected into the cytosol, plasmid DNA has been observed to remain at the site of injection [4, 106] . Biotin-or goldlabelled plasmids microinjected into the cytoplasm of primary rat myotubes were sequestered principally by cytoplasmic elements, indicating impediment of the diffusional freedom of plasmid DNA in these cells [4] . On the other hand, oligonucleotides < 250 bp rapidly enter the nucleus after cytoplasmic microinjection, suggesting that decreased plasmid size or injection in the direct proximity of the nucleus could potentially increase DNA transport [4] . In agreement with the idea that DNA nuclear uptake is dependent on its size is the evidence that, although 1-6 kb DNA rapidly enters isolated or digitonin-permeabilized nuclei [107, 108] , it cannot be detected in the nuclei of intact cells after cytoplasmic injection [37, 107, [109] [110] [111] [112] . Microinjected oligonucleotides and other short DNA fragments (PCR products etc.), on the other hand, can easily enter the nucleus by diffusion [37, 111] . The relative homogeneity of the distribution of these microinjected oligonucleotides suggests that it is the mass of the DNA, rather than specific interactions, that are responsible for the limited diffusion of larger DNAs [37, 105, 113] , which may be related to the high viscosity of the cytosol [106] . Direct measurement of the translational diffusion of fluorescein-labelled double-stranded DNA fragments of various sizes (21 bp-6 kb) after cytoplasmic microinjection was examined using FRAP (fluorescence recovery after photobleaching) [110, 113] . DNA of > 2000 bp was, to all intents and purposes, immobile during the period of measurement (DNA diffusion coefficient < 0.01), and DNA of > 250 bp had severely impaired lateral mobility in cytoplasm compared with water [110] . It was suggested [110] that this was due to molecular crowding, resulting in extensive non-specific binding to immobile obstacles. This is supported by experiments in which disruption or reorganization of the actin cytoskeleton resulted in a significant increase in the diffusion of DNA through the cytoplasm or enhanced gene delivery to the nucleus [114, 115] . Similar results were seen in cells treated with agents to deplete vimentin or keratin [112] . In contrast, when GFP (green fluorescent protein)-expressing plasmids were microinjected into the cytoplasm of cultured cells, a significant level of expression was observed, which was greatly reduced if the microtubular network was depolymerized using nocodazole [116] . Co-injection of an antidynein inhibitory antibody with the plasmid DNA also resulted in decreased expression, indicating that dynein is likely to play a role in this microtubule-facilitated nuclear transport of DNA. Together, these results demonstrate that the cytoplasm is a significant impediment to the transport of DNA to the nucleus, but that cytosolic components, such as the microtubular network, can help to facilitate this process.
Stability of DNA
Limited diffusion of DNA through the cytoplasm increases its exposure to cytosolic nucleases and therefore favours its degradation. FISH (fluorescence in situ hybridization) and quantitative single-cell fluorescence video-image analysis have demonstrated that both single-and double-stranded DNA are eliminated from the cytoplasm of HeLa and COS-1 cells with an apparent halflife of 50-90 min [117] , and disappear from C2C12 cells and myotubes within 4 h [118] . These results were confirmed by monitoring the rapid turnover of fluorescent DNA after microinjection [112] . Inhibition of cytosolic nucleases increased DNA stability in vitro [101] and resulted in increased transgene expression [119, 120] , highlighting the idea that instability of DNA in the cytoplasm may be a contributing factor to the low efficiency observed with non-viral gene-delivery vectors [101, 105, 121] . The compaction of the DNA with vectors, such as PEI, offers increased resistance to nucleases [101, 122] , but the DNA almost certainly has to dissociate from the vector in order to enter the nucleus [97] .
Nuclear entry of DNA Nuclear entry of DNA by passive diffusion As mentioned above, the NPC constitutes a size-dependent barrier against diffusion of molecules into the nucleus. Microinjection studies revealed that DNA fragments < 250 bp were able to diffuse freely into the nucleus, whereas larger fragments were not [37, 110] . The accumulation of smaller DNAs was temperature-, ATP-and concentration-independent, which is consistent with passive diffusion as the mode of entry [37] . The observations that labelled oligonucleotides < 25 bp can be detected in the nuclei of cells within seconds of cytoplasmic microinjection supports the idea that DNA smaller than the diffusional cut-off of the NPC (< 250-310 bp) have unrestricted access to the nucleus as expected [105, 109, 123] and are retained inside via immobilization on to high-affinity nuclear-binding sites [109, 123] . It is therefore unlikely that larger pieces of DNA, such as plasmid or therapeutic DNA fragments, are able to enter the nucleus by diffusion alone. There have been reports, however, that demonstrate nuclear entry of larger DNA fragments via passive diffusion, but these reports relied upon isolated nuclei, reconstituted from either Xenopus oocyte extracts [108] or mechanically perforated HTC (hepatoma tissue culture) cells [124] . In either case, the experimental procedures almost certainly altered the diffusional barrier of the nucleus.
Active transport of DNA by the cellular nuclear import machinery Several groups have reported active transport of larger DNA fragments through the NPC, although this remains an extremely inefficient process [51] . Nuclear localization of plasmid DNA in postmitotic nuclei of primary rat myotubes [4] and the nuclei of CV-1 cells [125] has been shown to be a dose-and energydependent process. Furthermore, nuclear import and gene expression was blocked by wheat-germ agglutinin, which inhibits transport through the NPC by binding to N-acetylglucosamine residues on NPC proteins, or antibodies against NPC components [4] . Dean and colleagues [103, 126] extended this approach with direct detection of the DNA using in situ hybridization, and found that DNA active transport via the NPC is not only energydependent, but also sequence-specific, with the SV40 enhancer region being sufficient to promote active transport into the nucleus [103] . This region has also been shown to be sufficient to increase gene expression and has been called DTS (DNA nuclear targeting sequence) [11] . Electroporation of DNA with this DTS resulted in a 10-fold higher gene expression due to both increased and faster nuclear uptake of the DNA and transcriptional enhancement [127] . Other DTSs have been reported, some of which function in a cell-specific fashion [11] , such as the smooth muscle γ -actin promoter region [128] . DNA nuclear import is thought to be a protein-mediated mechanism and, indeed, although the addition of purified Imp α, Imp β and RanGTP is sufficient to reconstitute protein nuclear import, DNA nuclear import also requires nuclear extracts [129] .
STRATEGIES TO INCREASE THE NUCLEAR TARGETING OF DNA
Due to the large volume of work demonstrating the inefficiency of non-viral gene transfer and that inadequate nuclear transport of DNA is largely responsible for this, various strategies to improve DNA nuclear targeting in non-viral vectors have been investigated, including electroporation techniques and coupling of DNA to NLS-containing proteins and/or peptides.
Electroporation
Electroporation involves subjecting living cells to short electrical pulses, resulting in transient pores forming in the cell membrane due to the induction of transmembrane potential differences [130] . It is a technique that has been extensively employed to introduce DNA into cultured cells. The combination of both electrical stimulation and chemical disruption (a process known as nucleofection) to enable disruption of both the nuclear and cytoplasmic membranes is another widely used approach and is particularly well suited to non-dividing cells [131, 132] . Electrical impulses can also be applied in vivo either transcutaneously or using electrodes that directly contact muscles to enable DNA transfer into peripheral tissue, usually the calf muscle [133] . This not only allows for the entry of DNA into the cytosol, but also facilitates electrophoretic movement of DNA into the nucleus, thus providing some level of protection against degradation by cytosolic nucleases [133, 134] .
Using the nuclear import machinery
Recruitment of the nuclear import machinery to facilitate efficient gene transfer requires the direct or indirect coupling of NLS sequences to the DNA (Table 1 ) [105, 106] . This can be achieved by associating the negatively charged DNA to the NLS, on the basis of the relative positive charge of the sequence, or alternatively via covalently coupling the NLS to either components of the non-viral delivery vector or directly to the DNA backbone ( Figure 4 ) [51] .
Non-covalent association of NLSs to DNA NLS peptides can be associated with DNA via electrostatic interactions. Microinjection of a low-copy number of plasmid DNA encoding a luciferase reporter gene complexed with peptides of the T-ag NLS into the cytosol of zebrafish embryos resulted in rapid nuclear targeting of the plasmid and transgene expression [135, 136] . Similar results were observed with in vitro-reconstituted sea-urchin pro-nuclei, where it was observed that NLSplasmid complexes were imported into the nucleus in a twostep process involving binding to and translocation through the NPC [137] . A tetrameric NLS peptide containing four copies of the T-ag NLS (PKKKRKV) separated by glycine residues promoted increased transgene expression and nuclear uptake in a variety of cell lines, and was able to condense the plasmid DNA into small complexes [138] . Furthermore, the T-ag NLS has been successfully utilized to enhance gene transfer mediated by cationic liposomes by at least 3-fold [6, 139, 140] . One study also demonstrated that cationic lipoplexes containing an NLS peptide became larger and more spherical when viewed under electron microscopy [6] , which may contribute to the observed enhancement, as large lipoplexes have been shown to give higher gene-transfer efficiency [141] [142] [143] . Liposome-mediated DNA delivery was also enhanced by the association of short peptides derived from human histone or protamine (a DNA-condensing protein found in spermatozoa) prior to the addition of the lipids [144] . Short peptides were chosen due to the concern that whole protein may be difficult to derive or represent an immunological target. Protamine and histones have, however, been successfully utilized as complete proteins to mediate gene transfer with promising results (see below) [145] [146] [147] [148] [149] .
Another approach is to link the NLS to a DNA-binding peptide. For example, the M9 NLS sequence was conjugated to a scrambled version of the T-ag NLS peptide (Figure 4, strategy 1A) and used to transfect DNA into endothelial cells by lipofection, resulting in a 63-fold increase in marker gene expression [150] . In this case, the scrambled T-ag NLS served to enhance peptide binding to DNA, since the M9 NLS sequence is not highly basic.
As electrostatic association of NLS to DNA may interfere with the transcriptional activity of the DNA, sequence-specific non-covalent alternatives have also been investigated ( Figure 4 , strategy 1B) [51] . PNA (peptide nucleic acid) molecules linked to the T-ag NLS bound to plasmid DNA in a sequence-specific fashion in a region outside that involved in gene expression [151] . When combined with PEI-mediated delivery, a modest increase in transfection efficiency (5-8-fold) was observed compared with naked DNA, but whether the increase was specifically due to the NLS peptide or due to increased nuclear import of the plasmid was not demonstrated conclusively. Active nuclear transport of a fluorescently labelled version of this PNA-NLS-oligonucleotide complex was, however, shown subsequently [152] .
A triple helix-forming padlock oligonucleotide was used to couple an NLS peptide to a luciferase-expressing plasmid, without disrupting transcription, but no enhancement of transgene expression was observed when using cationic liposome-or cationic polymer-mediated transfection [153] . This result was similar to previous attempts using the T-ag NLS coupled to a triple helix oligonucleotide [154] . Finally, NLS-streptavidin conjugates were coupled to biotinylated DNA, resulting in increased nuclear uptake, strictly dependent on the size of the DNA in digitoninpermeabilized cells, or in increased expression after microinjection into the cytoplasm of live HeLa cells [109] .
NLSs coupled to delivery vector components
Instead of using the NLS itself to condense DNA, several groups have coupled NLS peptides to DNA-condensing components of non-viral vectors. The T-ag NLS coupled to polylysine showed enhancement of transferrinfection (transferrin-polylysinemediated transfection) of a β-galactosidase-expressing reporter plasmid, which could be attributed to significant Imp α/β binding [7] ; polylysine itself, complexed with DNA, is not recognized by Imp α/β.
Other examples of increased nuclear targeting promoted by coupling molecules to carrier components include using: melittin, a component of bee sting venom, or the adenovirus hexon protein to enhance PEI-mediated gene delivery [51, 155, 156] . Microinjection of melittin-containing PEI-DNA complexes increases gene expression approx. 4-fold above that of PEI-DNA complexes alone [156] . This activity was inhibited by wheat-germ agglutinin, indicating involvement of the NPC, and is postulated to occur via a small cationic cluster at the C-terminus. Hexon protein-containing PEI-DNA complexes showed a 10-fold increase in reporter gene [138] and the T-ag NLS covalently coupled to polylysine [7] , where polylysine mediates DNA binding. Other NLSs have also been employed in this fashion, including the M9 NLS, coupled to a basic sequence (a scrambled version of the T-ag NLS), where the basic sequence mediates the interaction with DNA [150] . (B) Sequence-specific NLS-DNA interactions that have been tested include coupling of NLS sequences to DNA via a PNA clamp [151] or through a padlock oligonucleotide [153] that forms a triple helix with specific DNA sequences. Another approach is to conjugate streptavidin-coated NLS peptides to DNA biotinylated at specific sites [109] . (2) Covalent attachment of NLSs to DNA can include random coupling of NLS sequences via chemical or photo-activation [8, 157, 158] . Alternatively, a sequence-specific attachment can be achieved via a triple helix-forming oligonucleotide and photo-activation [154] . On the other hand, NLS sequences can be ligated to hairpin sequences on the ends of linear DNA sequences [140, 160, 161] or attached to PCR primers used to generate linear DNA [161] . (3) DNA can be associated with nuclear proteins containing endogenous NLSs. This can be via ionic interactions with nuclear proteins, such as histones or protamine [149, 179] , or alternatively viral proteins, such as the A. tumefaciens virulence VirD2 and VirE2 proteins [164] , which attach to DNA via covalent and ionic interactions respectively. expression after cytoplasmic microinjection into Xenopus oocytes when compared with PEI-DNA complexes alone [155] . Again, significant inhibition by wheat-germ agglutinin was observed.
Direct attachment of NLS sequences to DNA
To prevent dissociation of the DNA and the NLS peptide during intracellular trafficking, chemical or photochemical reactions have been used to link them covalently ( Figure 4 , strategy 2) [106, 141] . Both the size limit and the intensity of DNA nuclear transport could be enhanced by covalent attachment of an NLS, whereby conjugation of a 900-bp expression cassette to an NLS (CKKKSSSDDEATADSQHSTPPKKKRKVEDPKD-FPSELLS, important residues in the NLS are highlighted in bold) increased both its nuclear transport and expression in living cells after microinjection [109] . In contrast, other studies which examined non-specific covalent attachment of various NLSs to larger pieces of DNA have had less encouraging results [51] .
Nuclear uptake of plasmid DNA cross-linked to 25-100 NLS peptides (CGYGPKKKRKVGG) per kb of DNA via the DNA alkylating moiety cyclopropapyrroloindole demonstrated that, when more than 40 T-ag NLS peptides per kb were present, nuclear accumulation of the conjugated DNA in digitoninpermeabilized cells occurred via the classical nuclear import pathway [157] . However, increased nuclear uptake was not observed after microinjection of the modified plasmid into the cytoplasm of cultured cells, possibly due to sequestration of the DNA in the cytoplasm, as has been observed for naked DNA [106] . Alternatively, this could be due to the poor functionality of the particular NLS peptide used; T-ag NLS peptides that include the CK2 site (op-T-NLS; Table 1 ), for example, mediate nuclear import 100 times faster than PKKKRKV sequence alone (see also the NLSs section). Alternatively, this may be related to inherent problems with the in vitro nuclear transport system with digitonin-permeabilized cells, in that the nuclear membrane can be partially disrupted through chemical treatment. A preferential alternative system using mechanically perforated cells and Texas Red-labelled dextran as a marker of nuclei integrity (e.g. [124] ) has been extensively used to examine the nuclear transport of proteins, and may possibly resolve some of these issues, although the use of in vivo systems is, as always, preferential.
Covalent attachment of the T-ag NLS to plasmid DNA by photoactivation resulted in significant binding to Imp α when 10 NLS peptides (PKKKRKV) were present, but the conjugated DNA could not be detected by fluorescence microscopy in the nucleus of NIH 3T3 cells after microinjection into the cytoplasm [158] . No significant enhancement of cationic lipid-mediated transfection was observed when three or eight NLS peptides were coupled to the DNA, and a 60% decrease in expression occurred in the presence of 43 NLS peptides. Similar results were observed with T-ag NLS peptides (PKKKRKV) that were randomly coupled to plasmid DNA via diazocoupling, resulting in enhanced binding to Imp α [8] . It was observed that both the number of NLS peptides and the length of spacer used were important for enhanced binding to Imp α and gene expression. The coupling of approx. five NLS peptides to DNA via a 3.4 kDa PEG [poly(ethylene glycol)] spacer stimulated complex formation with Imp α, and resulted in 4-fold increase in gene expression compared with unmodified plasmid, but no nuclear uptake of the NLS-plasmid conjugates was observed after microinjection into COS-7 cells.
It is important to note at this point that the evidence is mixed with regards to the influence of the number of NLS peptides present. As mentioned above, it has been reported that the more numerous NLSs were present, the stronger the association with Imps, but with no concomitant increase in expression [157, 158] .
However, significant enhancement in reporter gene expression was achieved with only one NLS peptide linked to a 4000-bp linear DNA fragment [140] .
Covalent attachment of the IBB domain of Imp α to plasmid DNA, although showing binding to Imp β, did not increase cationic liposome-mediated transfection efficiency [159] . Noncovalent association of the IBB peptide to the DNA did, however, result in a 20-fold increase in transfection efficiency of the lipoplexes used in the study [159] .
These results all demonstrate that non-specific covalent attachment of NLS peptides to plasmid DNA does not result in increased gene expression, despite detectable binding to Imps. This may be due to many of the other cellular barriers already discussed, including poor cytoplasmic trafficking and a high rate of metabolic turnover of DNA, or it may be due to transcriptional inactivation of the DNA after covalent attachment to NLS peptides.
To prevent inhibition of reporter gene expression, sequencespecific associations of NLS peptides to DNA have been explored [141] . One example used a 3.3-kb linearized plasmid DNA, which was subsequently capped with hairpin oligonucleotides to prevent degradation by cellular nucleases [140] . A T-ag NLS-derived peptide (PKKKRKVEDPYC) was coupled to the 3 -hairpin cap. A 10-to 1000-fold increase in luciferase gene expression was observed when compared with linear DNA without the NLS peptide. The level of enhancement was dependent on the cell type used, with rapidly growing cells, such as NIH 3T3 or HeLa cells, displaying the most, and slow-or non-growing cells, such as neuronal or macrophage cells, displaying the least. However, the nuclear uptake of these constructs was not directly assessed. Another significant drawback of this technique was that the chimaeric DNA molecule proved extremely difficult to produce in large quantities, potentially limiting future pharmaceutical development [140, 141] .
Following this line of thought, a single NLS peptide was coupled to a specific site on plasmid DNA by covalent triple helix formation and photo-activation, during which the plasmid remained supercoiled [154] . The benefits of this strategy include both the ability to introduce multiple NLSs by incorporation of numerous attachment sites, as well as large-scale production with relative ease [141] . Nonetheless, despite functional conjugates being produced that could bind to Imp α, transgene expression was not increased significantly compared with non-modified plasmid either in vitro or in vivo [141, 154] . This may be partially due to the large size of the plasmid DNA, as discussed above. Similar results were obtained with COS-7 cells, where covalent attachment of the T-ag NLS to only the 3 -hairpin or both hairpins attached to linearized plasmid DNA did not result in increased transfection efficiency [160] . Similarly, covalent attachment to only the 5 -hairpin did not result in increased transfection efficiency, nor was nuclear uptake of the DNA observed in digitoninpermeabilized cells [51, 161] .
Association of DNA with viral proteins
Viruses whose life cycles involve replication in the nuclei of host cells have evolved numerous proteins with NLS activity, which enable recognition by cellular Imps to effect nuclear transport [106] . Apart from conventional viral-mediated gene delivery, in which DNA is packaged in modified or attenuated virus particles, numerous viral proteins themselves have been used to enhance non-viral-mediated gene transfer.
The major core protein VII from adenovirus type 2 was associated with plasmid DNA by ionic interactions and used to transfect cells by direct application to the surrounding medium [149] . The amount of radiolabelled DNA in the subcellular fractions of transfected cells was assayed, and it was shown that approx. 40 % of the introduced DNA reached the nucleus in 2 h, which was associated with an increase in gene expression in mammalian and insect cells. However, it could not be excluded that the nuclear fraction was exaggerated by the presence of plasmid DNA bound to the NE and not internalized into the nucleus [141, 149] .
Viral proteins have also been coupled to cationic polymers to enhance their transfection efficiency. The adenovirus hexon protein was covalently coupled to PEI, with hexon-PEI-DNA complexes giving 10-fold greater transgene expression in HepG2 cells than PEI-DNA alone [155] . This increase was consistent with the hexon protein, although it does not contain a clearly identified NLS, mediating nuclear delivery of the plasmid via the NPC, rather than an increase in cellular uptake.
Finally, viral proteins that have DNA compaction, as well as nuclear localization, properties can also be used [51] . It has been reported that the C-terminal region of the accessory protein Vpr (viral protein R) of HIV-1 mediates DNA condensation and pHindependent delivery into a variety of human and non-human cell lines, with efficiencies comparable with PEI and 10-to 1000-fold greater than polylysine. This portion of Vpr adopts an α-helical conformation and mediates gene transfer by DNA condensation and membrane-destabilizing properties [162] . It has also been demonstrated to have a capacity for protein transduction [163] , making it an exciting prospect for gene therapy, although DNA delivery by the Vpr C-terminus has been shown to be mediated by endocytosis [162] (see also the Endocytotic uptake pathways section). The HIV-1 integrase protein has also been investigated for its ability to deliver DNA to nuclei in an in vitro-reconstituted nuclear transport system [124] . Integrase was shown to possess potent nucleophilic properties, demonstrating high affinity for Imp α/β, as well as its obvious DNA-binding propensity. Integrase was found to be capable of mediating the nuclear import of DNA in a semi-intact cell system. Although these results are yet to be confirmed in a whole-cell assay, the large size of the delivered DNA (approx. 14 kb) makes integrase an interesting prospect for future research.
Many other proteins have also been investigated, including some bacterial proteins, such as the Agrobacterium tumefaciens virulence proteins VirD2 and VirE2 [164] (Figure 4, strategy 3) . These proteins allow for the efficient delivery of single-stranded T-DNA (transfer DNA) into plant cells. VirD2 is covalently attached to the 5 end of the DNA and VirE2 binds along its length. Both proteins contain bipartite NLSs that mediate nuclear import in plant cells. Reconstituted T-DNA complexes containing single-stranded DNA and the viral proteins were shown to allow in vitro nuclear import of the DNA in HeLa cells in an Imp α-dependent fashion, consistent with classical nuclear import. However, nuclear transport of this reconstituted complex or genetransfer efficiency have not been investigated in living cells. In addition, the DNA cleavage step required to attach VirD2 to the DNA is incompatible with therapeutic applications [141] .
Association of DNA with karyophilic proteins
Despite being technically classified as non-viral gene-delivery vehicles, the use of virally or bacterially derived proteins is likely to present problems of pathogenicity or immunogenicity due to their very nature. The use of cellular proteins that contain both DNA-binding and nuclear transport abilities is therefore highly attractive. Many proteins in this category can be combined into a synthetic modular carrier system that incorporates various domains with different functions.
Imp β . Due to its integral role in the nuclear transport of cellular proteins, association of plasmid DNA to Imp β may result in increased nuclear uptake and therefore enhanced gene expression. Biotinylated plasmid DNA was coupled to recombinant streptavidin-fused Imp β, with various spacer lengths and different numbers of introduced biotins [165] . Using these constructs, a 2.6-fold increase in the number of NIH 3T3 cells expressing the reporter gene was observed, although biotinylation of the DNA resulted in reduced gene expression, as has been observed previously [51] .
Transcription factors. The N-terminal 147 residues of the yeast transcription factor GAL4 contain a DNA-binding domain that is specific for a 17 bp nucleotide-recognition sequence. The first 74 amino acids have also been shown to function as an NLS, in that they are able to target proteins to the nucleus [92, 166] . It has been used previously within gene-delivery vehicles, for example, as a fusion protein with Erb-2 and endotoxin, where Erb-2 targets specific cell types, endotoxin promotes endosomal escape and GAL4 promotes DNA binding [167] . It has also been used as part of a GAL4-invasin fusion protein, where the invasin moiety effects internalization of the DNA by binding to cell-surface integrins [168] . Further GAL4-fusion proteins that have been tested include those fused to the herpes virus protein 16 activation domain, with [169] or without [170] the ligand-binding domain of the human progesterone receptor hPRB891. However, it has been demonstrated that the DNA binding and nuclear targeting activities of GAL4 are mutually exclusive [92] . Inclusion of the T-ag NLS via a modified polylysine resulted in a 'switching' of the nuclear transport pathway from Imp β-to Imp α/β-mediated, resulting in enhanced GAL4-mediated gene delivery [87] ; clearly, the efficiency of nuclear transport is an important factor, so that the specific NLS used (see also the NLSs section) is critical to targeting particular Imp-dependent nuclear import pathways. The same study [87] also demonstrated enhanced cell-specific delivery of DNA mediated by a chimaeric GAL4-α-melanocytestimulating-hormone fusion protein.
As mentioned previously, a region of the SV40 DNA containing the origin of replication and the early and late promoters has been shown to localize to the nucleus in a sequence-specific fashion [126] , and this is suggested to be through complex formation to the DNA of proteins that contain NLSs in the cytoplasm, which then mediate its nuclear transport [103, 126] . Due to the sequences involved, the probable candidates for these adaptor proteins are therefore transcription factors and origin-binding proteins. In support of this, the region of SV40 DNA in question does indeed contain numerous binding sites for various transcription factors, including Sp1 (stimulating protein-1), AP-1 (activator protein-1), Oct-1 and NF-κB (nuclear factor κB) [171] . In agreement with this idea, it was demonstrated that incorporation of an SV40 enhancer, either 5 or 3 to a CMV (cytomegalovirus) promoter-driven gene, enhanced expression as much as 20-fold in muscle cells in vivo [172] . The minimal region required for this enhancement is a single copy of a 72-bp element of the SV40 enhancer.
Using this theory, a model was developed whereby transcription factors bind to DNA in the cytoplasm to create DNA-protein complexes, which in turn can enter the nucleus using the nuclear import machinery [126, 128] . The model predicts that, by using DNA elements that contain binding sites for specific transcription factors that are expressed in unique cell types, plasmids could be created that enter the nucleus in a cell-specific manner. This was demonstrated using the promoter from the smooth muscle cell γ -actin gene, which is selectively expressed in smooth muscle cells, to generate a series of reporter plasmids whose expression is limited to smooth muscle [128] . These plasmids localize to the nucleus after cytoplasmic microinjection into smooth muscle cells, but remain in the cytoplasm of fibroblasts and CV-1 cells. In contrast, a similar plasmid carrying the SV40 enhancer localized to the nucleus of all cell types tested. These plasmids represent a new class of cell-specific vector, the specificity of whch is at the level of plasmid DNA nuclear import.
DNA vectors have also been designed to include repetitive binding sites for the inducible transcription factor NF-κB, which contains the NLS sequences and is transported to the nucleus in an Imp-dependent fashion [173] . Plasmid nuclear entry was enhanced 12-fold, concomitant with an increase in gene expression. By manipulating the position of the NF-κB-binding sites, transcriptional enhancement could also be observed, resulting in a further 19-fold increase in gene expression. However, the majority of plasmids still failed to reach the nucleus, possibly due to cytoplasmic aggregation. It was observed that the NLS-containing NF-κB proteins p50 and p65 not only mediated the nuclear transport of DNA, but also its migration along microtubules through the cytoplasm towards the nucleus [174] , as has also been observed previously (see earlier section 'Diffusion of DNA through the cytosol'). This transport was dynein-dependent and mediated by the Imp proteins that recognized the NLS sequences. Again, not all of the plasmid DNA reached its target destination, possibly due to cytoplasmic aggregation, which would significantly impair transport through the cytosol, even if it were mediated by microtubules.
HMG (high-mobility group)-box proteins.
The DNA-interacting HMG-box proteins can be classified into two groups [175] . The first are the chromatin-remodelling HMG proteins, which bind and bend specific DNA motifs [141, 175] . NLSs have been identified in some of these proteins, with both mono-and bi-partite types detected in the HMG domain [141] . The second group are the chromatin-associated HMG-1/HMG-2 proteins, which bind DNA non-specifically and have been associated with increased gene expression [141, 175] . Although found in both the cytoplasm and the nuclei of mammalian cells, microinjection experiments indicate rapid nuclear localization abilities [141, 176] .
It has been demonstrated that condensation of DNA using HMG-1 is sufficient to promote efficient gene transfer in cultured mammalian cells [177] . Using Sendai virus HVJ (haemagglutinating virus of Japan) to fuse DNA-loaded ganglioside liposomes with red blood cell membrane vesicles containing HMG-1 resulted in rapid transport of DNA to the nuclei of cultured cells [178, 179] . HMG-1 did not appear to increase the level of gene expression, but instead significantly reduced the time taken to reach maximal expression. Whether this may be due to increased nuclease resistance produced by the complex due to increased DNA compaction or through an increased nuclear transport kinetic remains to be shown. In vivo gene transfer to the liver, heart or kidney has also been demonstrated using liposome-HVJ-HMG-1 complexes, with expression increased by 3-to 5-fold and prolonged expression in tissues observed [179] [180] [181] [182] . These liposome-HVJ-HMG-1 complexes have also been used for gene transfer in a mouse model of disseminated intraperitoneal cancer, with promising results [183] . HMG-1/HMG-2 and HMG-17 extracted from calf thymus by chromatographic separation of acid nuclear extracts were shown to be efficient DNA carriers for gene transfer, but CaCl 2 was found to be an important requirement in the medium for transfection to occur [184, 185] . Similarly, recombinant HMG-1 produced in the yeast Pichia pastoris was also shown to be an efficient gene-transfer agent [186] . A summary of the studies testing HMG proteins as genetransfer vehicles is presented in Table 2 .
Histones. Due to their innate DNA-binding, condensing and nuclease-protection properties, as well as their intrinsic NLSs, histones have been regarded as an attractive possibility for genedelivery vehicles for some time. Most work has focused on the linker histone H1 and its variants, but core histones have also been used [145, 146, 148, 187] , although there has been some contradictory results presented by various groups.
The primary unit of DNA compaction in eukaryotic cells is the nucleosome core particle, where approx. 146 bp of DNA are wrapped around a protein core, consisting of two copies of each of the four core histone proteins, H2A, H2B, H3 and H4 ( Figure 5 ) [188] . The intervening DNA between each nucleosome interacts with the H1 class of linker histones, promoting higher-order compaction [188] . Histones are abundantly synthesized during S-phase [77] , and, due to their essential role in DNA compaction and protection, histones contain specific NLSs that mediate their transport into the nucleus [189] . All four human core histones have been shown to possess two regions capable of nuclear targeting (Table 3) , a basic sequence in the N-terminus that resembles classical NLSs and a structure-based NLS, comprising of the entire central globular domain [189] , but the exact mechanisms of histone nuclear transport are not clearly understood.
H1 was purified from the active fraction of acid nuclear extracts and was shown to be efficient in mediating the transfer of reporter genes to cultured cells [184, 185, 190] . This transfection efficiency was dependent upon the presence of Ca 2+ and was enhanced by the addition of chloroquine, indicating an endocytotic mechanism of uptake. Ca 2+ dependence of H1-mediated gene transfer was subsequently confirmed [191] , and Ca 2+ was shown to help overcome serum inhibition of H1-mediated gene transfer [192] . In particular, it was shown that Ca 2+ did not affect the uptake of transfection complexes by cells, but instead were vital for reorganization of the complexes in endosomes/lysosomes and their subsequent release into the cytosol [193] .
H1 has been shown to significantly enhance the transfection efficiency of DOSPER [1,3-dioleoyloxy-2-(6-carboxyspermyl)propylamide] liposomal transfection reagents in primary cardiomyocytes [194] . This is significant as primary cell lines are generally recalcitrant to transfection. H1 has also been shown to augment the transfection efficiency of amphipathic polyamines in cultured mammalian cells, with transfection levels similar to those achieved using liposomal preparations, such as DOSPA/PE ({2,3-dioleyloxy-N-[2(sperminecarboxamido)-ethyl]-N,N-dimethyl-lpropanaminium trifluoroacetate}/phosphatidylethanolamine) [195] . To enhance H1-mediated gene transfer further, galactose and short integrin-specific cyclic RGD sequences were attached to H1 as ligands to target integrins or asioglycan receptors on target cells. The solubility of the DNA complexes, but not the gene-transfer efficiency, was increased above that mediated by unconjugated H1 [196] . Similar experiments performed in HepG2 cells did result in modest levels of transfection, up to 11 times greater than polylysine-based vectors, when ten galactosyl units were added to H1 [190] . Similarly, a series of H1-based fusion vectors containing EGFR (epidermal growth factor receptor) were able to efficiently transfect cells both in vitro and in vivo [197] . Finally, galactosylated H1 conjugated to an Epstein-Barr virus-based vector was able to deliver the therapeutic IL-2 (interleukin-2) gene into human hepatoma cells in vivo, although transfection was less efficient than liposome-mediated gene transfer [198] .
H1-mediated delivery of DNA, double-stranded RNA and siRNA (small interfering RNA) in both immortalized and primary cells was shown to be comparable with or better than liposomal delivery of the same nucleic acids [199] . In particular, a fragment containing the whole C-terminal domain and the middle portion of the protein (designated H1.4F) had the highest level of genetransfer efficiency, consistent with the C-terminal portion of H1 playing a role in DNA condensation and nuclear localization Nucleosomes form the first level of chromatin condensation, with consecutive nucleosomes joined by uncondensed 'linker' DNA so that they form a traditional 'beads on a string' array. To form higher-order chromatin structure, each of the nucleosome particles is condensed further through the action of H1 (not shown) into a 30 nm chromatin fibre. The histone tails form inter-nucleosome interactions that help with this higher-order compaction.
[ 187, 199, 200] . The use of recombinant H1.4F protein was associated with very low toxicity and was easily purified on a large scale from bacterial lysates, an important factor when considering its use as a gene-transfer vehicle. A recombinant histone (NLS-H1), which contained both the T-ag NLS (PKKKRKVEDK) and the C-terminal domain of H1 when complexed with DNA, mediated gene transfer into cultured cells, with efficiencies similar to DNA-cationic lipid complexes [201] . However, chloroquine was required for transfection to occur. It was shown that NLS-H1-DNA-lipofectin complexes resulted in 20-fold luciferase expression than DNA-lipofectin alone [201] . H1 purified from calf thymus also exhibited genetransfer enhancement in this system. In a similar series of experiments, NLS-H1 complexed with DNA and anionic liposomal formulations [DOPE (dioleoyl phosphatidylethanolamine) or phosphatidylserine] was found to mediate efficient gene transfer without the requirement for DNA encapsulation [202] . However, this left the DNA sensitive to DNase1 digestion and ethidium bromide intercalation. Finally, H1 has also been used to enhance the in vitro gene transfer of an antibody-based vector directed at tumour cell antigens, giving a 30-fold increase in reporter gene expression over the antibody-based vector alone [203] .
An H2A-based transfection method has also been developed, in which it was shown that H2A, but not H1, H2B, H3 or H4, can mediate efficient gene transfer of a β-galactosidase reporter gene into a number of cell lines, including COS-7 cells [145] . Transfection was dependent upon the DNA/histone ratio and was also a function of the molarity of the final Tris/acetate (pH 8) solution, but, unlike H1-mediated transfection, it did not require Ca 2+ or chloroquine. The transfection efficiency was found to depend on a 37-mer peptide from the N-terminus and was thought to be dependent on DNA binding and delivery to the nucleus [146] . Inclusion of a proline residue in the first turn of an α-helix in this peptide obliterates transfection efficiency, suggesting that the α-helical structure integrity is important to H2A-mediated gene delivery. Interestingly, as for H1, it is the NLS-containing portion of H2A (the N-terminus) that mediates gene delivery, underlining the fact that nuclear entry of plasmid DNA is a limiting step in gene delivery.
H2A was used in cancer immunotherapy to induce a cellmediated antitumour response by efficiently delivering cytokine genes encoding IL-2 and a single-chain IL-12 fusion protein [147] . H2A-mediated transfection of IL-2 induced natural-killercell-induced rejection of primary tumours in a murine neuroblastoma model, whereas delivery via the liposomal formulation SuperFect resulted in only a partial reduction in primary tumour growth. Similarly, H2A-mediated delivery of single chain IL-12 resulted in a greater release of interferon-γ than SuperFect alone.
H3 and H4 were tested individually or in combination with various lipofection reagents for their ability to transfect Jurkat Tcells [148] . Maximal transfection efficiency was observed with H3 or H4, with both the relative DNA/protein ratio and the incubation time critical for optimal transfection. In contrast with the results above, H2A and H1 were unable to mediate transfection in this system. However, similar to that observed for H2A, transfection did not require additional compounds, such as chloroquine or Ca 2+ , suggesting a non-endocytotic uptake mechanism.
Recently, engineered H2B proteins have also been utilized for efficient gene transfer [80] . These proteins were engineered to include a GFP tag and op-T-NLS to enable high-affinity recognition by Imp α/β. The engineered H2B proteins were able to mediate the efficient delivery of DNA into intact HeLa cells through the nonendocytotic process of histone-mediated transduction, with further enhancement achieved by utilizing a dimer of H2B and H2A. Subsequent nuclear delivery was accelerated approx. 2-fold by the addition of the op-T-NLS, resulting in increased expression of the reporter gene [80] . Similar to that observed for the other core histones, the transfection did not require additional compounds, such as Ca 2+ . Excitingly, these engineered H2B proteins have been used as part of a reconstituted chromatin-based delivery system that relies on transduction exclusively (Chromofection), with levels of transfection efficiency approx. 6 Some histone-like proteins from Archaea have also been utilized for gene delivery. A recombinant archael histone-like protein, HPhA, from the Pyrococcus horikoshii OT3 strain was shown to be an efficient DNA carrier in several cell lines [204] . Transfection efficiency of HPhA-mediated gene transfer is dependent upon the HPhA/DNA mass ratio, the incubation time and the presence of Ca 2+ . Encouragingly, the cytotoxicity of HPhA-mediated delivery was less than that of commonly used liposome-based gene-delivery systems. Another report used a recombinant histone-like protein TmHU from the hyperthermostable eubacterium Thermotoga maritima to mediate transfection into various cultured mammalian cells [205] . TmHU was also shown to enhance transfection mediated by other methods, such as lipofection. Despite being a bacterial protein, TmHU has two NLSs that may contribute to its increased DNA nuclear-targeting ability.
A summary of the studies using histones, histone-like proteins and HMG proteins is presented in Table 2 .
Other karyophilic proteins. There are several other karyophilic proteins that have been examined in terms of their ability to enhance gene delivery, such as protamine, a DNA-binding and compacting histone replacement found in spermatocytes. Protamine from salmon sperm, associated via ionic interactions with DNA, was rapidly transported to the nuclei of cultured cells [149] . Furthermore, protamine sulfate has been shown to efficiently condense plasmid DNA for delivery into several cell types using a number of different cationic liposome formulations, resulting in a modest enhancement of gene expression [206] .
An interesting study used a strategy termed steroid-mediated gene delivery [18] . This strategy exploits the GR (glucocorticoid receptor), which under normal circumstances is cytoplasmic. On hormone binding, GR translocates itself and its ligand to the nucleus [11, 50] . Dexamethasone, a GR ligand, was attached to DNA, either via a direct psoralen linker or via a PNA clamp, to enable selective placement of the steroid [18, 19] . When these steroid-complexed DNAs were transfected into GR-expressing non-dividing cells, gene expression was enhanced 20-to 40-fold compared with unmodified DNA.
Compacting DNA
The ability of DNA to traverse the NPC and, indeed, to migrate through the cytoplasm prior to nuclear uptake is inversely proportional to the size of the transfecting DNA [21, 105, 207] . Thus it is clear that compaction of DNA should result in an increased transfection efficiency [21, 144] . DNA compaction also has the increased benefit of enhancing DNA entry into cells, particularly via receptor-mediated delivery, and has also been shown to offer protection against degradation by nucleases [122, 148, 208, 209] . Particles comprising specifically designed cationic molecules (e.g. PEI or poly-L-lysine or organically modified neutral particles, such as silica or PEG, or naturally occurring DNA-condensation agents, such as histones and protamine) have been fairly extensively used, either alone or in combination with other nonviral vectors [7, 20, 105, 206] .
DNA compaction agents can reduce the size of DNA to well below the cut-off for the NPC (as small as 10 nm in diameter) and significantly enhance transfection efficiency above that of naked DNA [20, [210] [211] [212] . This is particularly true in non-dividing cells [213] . For example, microinjection studies using PEG-condensed DNA in post-mitotic cells demonstrated a 10-fold increase in transgene expression that was sensitive to the lectin wheat-germ agglutinin, suggesting nuclear import via the NPC [214] .
CONCLUSIONS
In order for a non-viral gene-delivery vector to be therapeutically viable, it needs to be able to transfect non-dividing cells efficiently, with the NE the most critical impediment to this process. Although there has been much success with the inclusion of NLS peptides/karyophilic proteins in delivery agents in terms of increased nuclear import, there has often been negligible enhancement of resultant gene expression. Therefore it is clear that attachment of an NLS to DNA alone does not necessarily result in higher transfection efficiency, rather an efficient non-viral genedelivery vector must have a combination of abilities, including DNA binding, DNA condensation, DNA protection, cellular entry and, most importantly, nuclear delivery, and at the same time it must not inhibit transcriptional activity of the gene product. The realization of this goal will require considered and innovative manipulations of current and future non-viral vectors in order to achieve the ultimate aim of safe, effective and, above all, efficient non-viral gene delivery.
